VAERS 2550820
GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 397B5-ADULT
- Staat
- WA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 21.02.1971
- Beginn
- 04.01.2023
- Tage bis Beginn
- 18.945,0
- Dosis
- N/A
- Route/Site
- IM / LA
Symptomtext
Vaccine given about 4:42 PM; without about 5-10 minutes at around 4:50 PM patient began experiencing subjective sensation of "facial swelling" and tingling sensation around the cheeks, forehead, and lips, no wheezing, no shortness of breath, no dizziness, no difficulty swallowing or throat swelling, no actual facial swelling noted, no nausea, no vomiting, no visual changes, some sensation of numbness about the lips. No chest pain. Symptoms persisted for about 25 minutes or so then began to abate by about 5:15 PM, nearly resolved by about 5:30 PM. Vital signs remained stable during this period, with O2 sat 99%. Patient was referred subsequently to ER for further observation and evaluation at about 5:35 PM in improved and stable condition. Unknown at this time about further disposition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None. BP 165/95, O2 sat 99% on RA. BP was elevated prior to receiving the Tdap.
- Aktuelle Erkrankungen
- Had covid-19 diagnosis by home test 12/17/22.
- Vorgeschichte
- Hypertension, Hypothyroidism
- Andere Medikamente
- Lisinopril, Albuterol, Ferrous sulfate, fluticasone, acyclovir.
- Allergien
- Propranolol--- >dizziness
- Vorherige Impfungen
- -